Compile Data Set for Download or QSAR
maximum 50k data
Found 695 Enz. Inhib. hit(s) with Target = 'Interleukin-2'
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50229786(5-[2,3-DICHLORO-4-(5-{1-[2-(2-GUANIDINO-4-METHYL-P...)
Affinity DataKi:  60nMAssay Description:Binding affinity to IL2 assessed as inhibition of IL2-IL2Ralpha interactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetInterleukin-23 receptor(Homo sapiens)
Centro De Investigaci£N Lilly

Curated by ChEMBL
LigandPNGBDBM50459752(CHEMBL4206167)
Affinity DataIC50:  2.70nMAssay Description:Binding affinity to recombinant human flag/His-tagged IL-23R (1 to 353 residues) expressed in HEK293F cells assessed as disruption of biotinylated IL...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM128384(US8802721, 1)
Affinity DataIC50:  3nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Mus musculus)
Sandoz Pharma

Curated by ChEMBL
LigandPNGBDBM50022815((3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33...)
Affinity DataIC50:  5nMAssay Description:The compound was evaluated in vitro for the immunosuppressive activity in interleukin-2 by interleukin-2 reporter gene assay (IL2-RGA)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetInterleukin-23 receptor(Homo sapiens)
Centro De Investigaci£N Lilly

Curated by ChEMBL
LigandPNGBDBM50459752(CHEMBL4206167)
Affinity DataIC50:  5.10nMAssay Description:Binding affinity to recombinant human flag/His-tagged IL-23R (1 to 353 residues) expressed in HEK293F cells assessed as disruption of biotinylated IL...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM128386(US8802721, 3)
Affinity DataIC50:  6.40nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50575333(CHEMBL4857063)
Affinity DataIC50:  8nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412467(N-(5-(5-ethyl-2-(5-methylisoxazol-3- yl)thiazol-4-...)
Affinity DataIC50:  8nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412475(5-ethyl-N-(5-(5-ethyl-2-(5- methylisoxazol-3-yl)th...)
Affinity DataIC50:  8nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412443(5-bromo-N-(5-(5-ethyl-2-(5- methylisoxazol-3-yl)th...)
Affinity DataIC50:  9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412445(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyridin-2-yl)...)
Affinity DataIC50:  9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412392(5-fluoro-4-methyl-N-(5-(5-(1-methyl- 1H-pyrazol-4-...)
Affinity DataIC50:  9nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50587599(CHEMBL5087453 | US11661419, Example 53 | US2023028...)
Affinity DataIC50:  10nMAssay Description:Inhibition of IL-2 in CD3/CD28 activated human CD4+ve Th cells preincubated for 15 mins followed by addition of immuno-cult and measured after 24 hrs...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412441(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyridin-2-yl)...)
Affinity DataIC50:  10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412442(5-chloro-N-(5-(5-ethyl-2-(5- methylisoxazol-3-yl)t...)
Affinity DataIC50:  10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412476(N-(5-(5-ethyl-2-(3-methylisoxazol-5- yl)thiazol-4-...)
Affinity DataIC50:  10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412479(N-(5-(5-ethyl-2-(isoxazol-3- yl)thiazol-4-yl)pyrid...)
Affinity DataIC50:  10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412489(N-(5-(2-chloro-5-(1-methyl-1H- pyrazol-4-yl)phenyl...)
Affinity DataIC50:  10nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50575331(CHEMBL4868242)
Affinity DataIC50:  11nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412447(N-(5-(5-ethyl-2-(5-methylisoxazol-3- yl)thiazol-4-...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412451(5-bromo-N-(5-(2-chloro-5- cyclopropoxyphenyl)pyraz...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412468(5-fluoro-4-methyl-N-(5-(5-methyl-2- (5-methylisoxa...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412481(5-chloro-N-(5-(2-chloro-5-(1-methyl- 1H-pyrazol-4-...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412488(5-bromo-N-(5-(2-chloro-5-(1-methyl- 1H-pyrazol-4-y...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412440(N-(5-(5-ethyl-2-(5-methylisoxazol-3- yl)thiazol-4-...)
Affinity DataIC50:  11nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412432(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyrazin-2-yl)...)
Affinity DataIC50:  12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412377(N-(5-(2-ethyl-5-(1-methyl-1H- pyrazol-4-yl)phenyl)...)
Affinity DataIC50:  12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412387(N-(2'-chloro-5'-(trifluoromethyl)- [1,1'-biphenyl]...)
Affinity DataIC50:  12nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412511(N-(5-(2-chloro-5- isopropoxyphenyl)pyrazin-2-yl)-4...)
Affinity DataIC50:  13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50587592(CHEMBL5090091 | US11661419, Example 7 | US20230280...)
Affinity DataIC50:  13nMAssay Description:Inhibition of IL-2 in CD3/CD28 activated human CD4+ve Th cells preincubated for 15 mins followed by addition of immuno-cult and measured after 24 hrs...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412446(5-cyano-N-(5-(5-ethyl-2-(5- methylisoxazol-3-yl)th...)
Affinity DataIC50:  13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412459(N-(5-(2-chloro-5- isopropoxyphenyl)pyridin-2-yl)-4...)
Affinity DataIC50:  13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412384(N-(5-(2-chloro-5-(5-methylthiazol-2- yl)phenyl)pyr...)
Affinity DataIC50:  13nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Mus musculus)
Sandoz Pharma

Curated by ChEMBL
LigandPNGBDBM50422041(GECLOSPORIN)
Affinity DataIC50:  13nMAssay Description:The compound was evaluated in vitro for the immunosuppressive activity in interleukin-2 by interleukin-2 reporter gene assay (IL2-RGA)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM50575332(CHEMBL4869725)
Affinity DataIC50:  14nMAssay Description:Inhibition of PHA-stimulated IL2 secretion in human Jurkat T cells preincubated for 10 mins followed by PHA addition and measured after 20 to 24 hrs ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412482(N-(5-(2-chloro-5-(1-methyl-1H- pyrazol-4-yl)phenyl...)
Affinity DataIC50:  14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412483(5-bromo-N-(5-(2-chloro-5-(1-methyl- 1H-pyrazol-4-y...)
Affinity DataIC50:  14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412465((Z)-N-(5-(1-(4-bromophenyl)prop-1- en-1-yl)pyridin...)
Affinity DataIC50:  14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412432(N-(5-(2-chloro-5- cyclopropoxyphenyl)pyrazin-2-yl)...)
Affinity DataIC50:  14nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM128385(US8802721, 2)
Affinity DataIC50:  14nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412472((Z)-5-fluoro-N-(5-(1-(4- methoxyphenyl)prop-1-en-1...)
Affinity DataIC50:  16nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM128388(US8802721, 117)
Affinity DataIC50:  16.5nMAssay Description:Jurkat cells were placed in a 96 well plate (0.5 million cells per well in 1% FBS medium) then a test compound of this invention was added at differe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412504(N-(5-(2-ethyl-5-((5-methylisoxazol-3- yl)oxy)pheny...)
Affinity DataIC50:  17nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412513((Z)-N-(5-(1-(4-bromophenyl)prop-1- en-1-yl)pyrazin...)
Affinity DataIC50:  18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412463(N-(5-(5-ethyl-2-(5-methylisoxazol-3- yl)thiazol-4-...)
Affinity DataIC50:  18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412473((Z)-methyl 4-(1-(6-(5-fluoro-4- methylnicotinamido...)
Affinity DataIC50:  18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412490(N-(5-(2-chloro-5-(1-methyl-1H- pyrazol-4-yl)phenyl...)
Affinity DataIC50:  18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412407(N-(5-(2-chloro-5-(2-methyl-2H- tetrazol-5-yl)pheny...)
Affinity DataIC50:  18nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412394(N-(5-(2-chloro-5-(3-fluoropyridin-4- yl)phenyl)pyr...)
Affinity DataIC50:  19nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
University Of California San Francisco

Curated by ChEMBL
LigandPNGBDBM412453((Z)-N-(5-(1-(4-bromophenyl)prop-1- en-1-yl)pyrazin...)
Affinity DataIC50:  20nMAssay Description:Human peripheral blood mononuclear cells (PBMCs) are prepared from heparinized human blood by separation over a Ficoll density gradient.PBMCs are sti...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 695 total ) | Next | Last >>
Jump to: